These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 20051876)
1. Effect of statins on the viability of macrophages and smooth muscle cells. Croons V; De Meyer I; Houten SM; Martinet W; Bult H; Herman AG; De Meyer GR J Cardiovasc Pharmacol; 2010 Mar; 55(3):269-75. PubMed ID: 20051876 [TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins in atherosclerosis and diabetes. Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194 [TBL] [Abstract][Full Text] [Related]
3. Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide. Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR J Pharmacol Exp Ther; 2007 Mar; 320(3):986-93. PubMed ID: 17135342 [TBL] [Abstract][Full Text] [Related]
4. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Luan Z; Chase AJ; Newby AC Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370 [TBL] [Abstract][Full Text] [Related]
5. Macrophages but not smooth muscle cells undergo benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-fluoromethylketone-induced nonapoptotic cell death depending on receptor-interacting protein 1 expression: implications for the stabilization of macrophage-rich atherosclerotic plaques. Martinet W; De Meyer GR; Timmermans JP; Herman AG; Kockx MM J Pharmacol Exp Ther; 2006 Jun; 317(3):1356-64. PubMed ID: 16537794 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. Turner NA; Midgley L; O'Regan DJ; Porter KE J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315 [TBL] [Abstract][Full Text] [Related]
7. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis. Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649 [TBL] [Abstract][Full Text] [Related]
8. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791 [TBL] [Abstract][Full Text] [Related]
10. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress. Martinet W; Croons V; Timmermans JP; Herman AG; De Meyer GR Br J Pharmacol; 2007 Oct; 152(4):493-500. PubMed ID: 17700714 [TBL] [Abstract][Full Text] [Related]
12. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells. Corpataux JM; Naik J; Porter KE; London NJ J Surg Res; 2005 Nov; 129(1):52-6. PubMed ID: 16087194 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549 [TBL] [Abstract][Full Text] [Related]
14. Selective clearance of macrophages in atherosclerotic plaques by autophagy. Verheye S; Martinet W; Kockx MM; Knaapen MW; Salu K; Timmermans JP; Ellis JT; Kilpatrick DL; De Meyer GR J Am Coll Cardiol; 2007 Feb; 49(6):706-15. PubMed ID: 17291937 [TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice. Van Herck JL; De Meyer GR; Martinet W; Bult H; Vrints CJ; Herman AG Basic Res Cardiol; 2010 Jan; 105(1):39-50. PubMed ID: 19693627 [TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904 [TBL] [Abstract][Full Text] [Related]
18. Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells. Martinet W; Schrijvers DM; Timmermans JP; Bult H Br J Pharmacol; 2008 Jul; 154(6):1236-46. PubMed ID: 18469840 [TBL] [Abstract][Full Text] [Related]
19. Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Wang LH; Chen JZ; Sun YL; Zhang FR; Zhu JH; Hu SJ; Wang DH Int J Cardiol; 2005 Apr; 100(3):467-75. PubMed ID: 15837092 [TBL] [Abstract][Full Text] [Related]
20. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Hughes A; Rogers MJ; Idris AI; Crockett JC Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]